Position
ALGERT GLOBAL LLC in Allogene Therapeutics, Inc.
Back to the book · All holders of ALLO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $210$0.00 → $0.00
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 196.4K | $269 | — | — | — | 0.0% |
| Q1 2026 | 464K | $1.13K | $0.00 | $210 | $653 | 0.0% |